25
Participants
Start Date
April 30, 2006
Study Completion Date
January 31, 2008
DN-101 (calcitriol) - Drug
Columbia Presbyterian Medical Center, New York
Piedmont Hematology Oncology Associates, Winston-Salem
Tyler Cancer Center, Tyler
Pacific Hematology Oncology Associates, San Francisco
Kaiser Permanente Medical Group, Northern California, Vallejo
Alta Bates Comprehensive Cancer Center, Berkeley
NW Kaiser Permanente Portland, Portland
Northwest Cancer Specialists Vancouver Office, Vancouver
Alta Bates Comprehensive Center, Portland
Oregon Health & Science University, Portland
University of Pittsburgh,William Copper Ambulatory Care, Pavillion Hellman Cancer Center, Pittsburgh
Tom Baker Cancer Centre, Calgary
Cross Cancer Institute, Department of Medicine, Edmonton
Lead Sponsor
Novacea
INDUSTRY